Related Experiment Video
Updated: Jan 12, 2026
10:10
A 3D Human Lung Tissue Model for Functional Studies on Mycobacterium tuberculosis Infection
Published on: October 5, 2015
19.4K
Charting the Course in Post-Tuberculosis Lung Disease: From Inflammation to Intervention.
Win Pa Pa Thu1, Ting Huey Hu1, Lia D'Ambrosio2
1Infectious Diseases Translational Research Programme, Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore.
Archivos De Bronconeumologia
|November 1, 2025
Summary
Post-Tuberculosis Lung Disease (PTLD) affects TB survivors with ongoing respiratory issues. Further research and collaboration are crucial for better patient outcomes and managing this growing public health challenge.
Area of Science:
- Pulmonary Medicine
- Infectious Diseases
- Public Health
Background:
- Post-Tuberculosis Lung Disease (PTLD) is a significant health issue for Tuberculosis (TB) survivors, causing persistent respiratory symptoms and reduced lung function post-cure.
- Its prevalence is highly variable, influenced by treatment, comorbidities, and environmental factors, disproportionately affecting high TB-burden regions.
Purpose of the Study:
- To review current knowledge on PTLD pathogenesis, clinical aspects, diagnostics, risk factors, and treatments.
- To identify critical knowledge gaps and implementation challenges in PTLD management.
- To propose research priorities and highlight the need for increased investment and global collaboration.
Main Methods:
- Comprehensive literature review of recent scientific and clinical evidence on PTLD.
- Synthesis of data on disease mechanisms, clinical manifestations, and diagnostic approaches.
- Analysis of risk factors, current treatment strategies, and implementation challenges.
Main Results:
- Recent advances have improved understanding of PTLD's development and progression.
- Key questions persist regarding patient risk stratification, early intervention, and healthcare system adaptation.
- Significant knowledge gaps and implementation hurdles remain in managing PTLD.
Conclusions:
- Addressing PTLD requires a multi-faceted approach involving clinical care, research, and policy.
- Increased research funding and international cooperation are essential to reduce the long-term impact of PTLD.
- Improving outcomes for TB survivors necessitates a focus on mitigating the burden of PTLD.
Related Concept Videos
01:28Pulmonary Tuberculosis II
1.4K
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
1.4K
01:28Pulmonary Tuberculosis V
532
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
532
01:31Pulmonary Tuberculosis III
914
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
914
01:26Pulmonary Tuberculosis IV
469
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
469
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K